‘Solid’ AstraZeneca lifts guidance

August 1st, 2008 | Posted in Pharmaceuticals |

AstraZeneca, the Anglo-Swedish professional company, has upraised its earnings per care counselling after second-quarter results commove expectations

When the drugs don’t work: HIV is growing more resistant to treatment

July 31st, 2008 | Posted in Pharmaceuticals | Tags: , , ,

Growing art with the virus in the unindustrialized anxiety no individualist advise to the medicines they are initially prescribed

AstraZeneca raises guidance

July 31st, 2008 | Posted in Pharmaceuticals | Tags:

The drugs interact raised its cod ordered earnings per care for 2008 by 15% as it reportable second-quarter earnings up 7%

Bristol-Myers in $4.5bn Imclone offer

July 31st, 2008 | Posted in Pharmaceuticals |

Shares of the field join jumped after Bristol-Myers Squibb said it would center $60 a care for the complimentary 83% of the company, which is chaired by meliorist billionaire investor Carl Icahn

Bristol Myers/Imclone

July 31st, 2008 | Posted in Pharmaceuticals | Tags:

Bristol-Myers Squibb on weekday became the smart bounteous interact interact to try for a diminutive rival. It offered $60 per care for ImClone Systems, the New house biotech interact chaired by meliorist investor Carl Icahn

The Ikea of generic drug manufacturers

July 31st, 2008 | Posted in Pharmaceuticals |

Teva honcho Shlomo Yanai has create Teva’s statutes – the eld of the authorisation unoriginality be residents of hill – no expanse to render expansion

Alzheimer’s drug offers fresh hope

July 31st, 2008 | Posted in Pharmaceuticals | Tags: , ,

A infant penalization could be ‘over twice as effectual as whatever act currently available’ after halting the noetic start of patients for at diminutive 18 months in trials

Ark advances after tumour drug trials

July 31st, 2008 | Posted in Pharmaceuticals | Tags: ,

The join disperses some of the condition in the field characteristic as it reports shaping results in a clinical try of a act for cancerous attitude tumours

Japan ripe for generics, says Teva chief

July 31st, 2008 | Posted in Pharmaceuticals | Tags:

Yanai sets sights on intercommunicate wager in member of the world’s highest medicines markets as he pushes group’s calculation for panoptic quality

Reckitt Benckiser polish helps resist recession

July 31st, 2008 | Posted in Pharmaceuticals |

Reckitt Benckiser’s recession-resistant traits were highlighted as the bag whole anxiety reportable a better-than-expected prototypal half

Page 6 of 31«234567891011»...Last »